Sort   by:  
 Page size 
UnknownVascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study).
Not available
S-EPMC10083528 | biostudies-literature
UnknownEffectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Not available
S-EPMC8930006 | biostudies-literature
UnknownFive-year trends in U. S. child and adolescent 24-hour movement behavior guideline adherence, 2018-2022.
Not available
S-EPMC12532870 | biostudies-literature
MetabolomicsA molecular index for biological age identified from the metabolome and senescence-associated secretome in humans.
Unlike chronological age, biological age is a strong indicator of health of an individual. However, the molecular fingerprint associated with biological age is ill-defined. To define a high-resolution signature of biological age, we analyzed metabolome, circulating senescence-associated secretome (S...
2024-01-24 | MTBLS1991 | MetaboLights
UnknownThe glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo.
Not available
S-EPMC6497458 | biostudies-literature
UnknownActivation of the glutamate receptor GRM1 enhances angiogenic signaling to drive melanoma progression.
Not available
S-EPMC4008638 | biostudies-literature
UnknownRiluzole enhances ionizing radiation-induced cytotoxicity in human melanoma cells that ectopically express metabotropic glutamate receptor 1 in vitro and in vivo.
Not available
S-EPMC3070864 | biostudies-literature
UnknownDeveloping and Evaluating Digital Interventions to Promote Behavior Change in Health and Health Care: Recommendations Resulting From an International Workshop.
Not available
S-EPMC5509948 | biostudies-literature
UnknownNeuromorphic one-shot learning utilizing a phase-transition material.
Not available
S-EPMC11047090 | biostudies-literature
UnknownRiluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.
Not available
S-EPMC5546507 | biostudies-literature
Sort   by:  
 Page size